Kaneka Corporation
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 6 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2024/02/07 | ¥80.10 | ¥69.95 | -12.7% |
| 2020/02/11 | ¥63.70 | ¥48.85 | -23.3% |
| 2019/08/07 | ¥92.00 | ¥53.53 | -41.8% |
| 2019/02/07 | ¥105.50 | ¥60.94 | -42.2% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
American Century ETF Trust-Avantis International Small Cap Value ETF
|
1.1M | +2.16% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
|
680.6K | 0.00% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
679.9K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
463.9K | +2.29% | |
|
Victory Portfolios-Victory Trivalent International Small-Cap Fund
|
316.5K | -0.09% | |
|
Templeton Global Smaller Companies Fund
|
302.6K | -15.31% |
Dividend History
Updated 2026/08/16| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥80 | -46.7% |
| 2025 | ¥150 | +30.4% |
| 2024 | ¥115 | +4.5% |
| 2023 | ¥110 | -4.3% |
| 2022 | ¥115 | - |
Financial Performance
2026/08/16 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥691,530M | ¥755,821M | ¥762,302M | ¥807,200M |
| Gross Profit | ¥196,649M | ¥198,926M | ¥204,214M | ¥225,644M |
| Operating Income | ¥43,563M | ¥35,088M | ¥32,579M | ¥40,050M |
| Pretax Income | ¥37,469M | ¥34,338M | ¥40,169M | ¥40,796M |
| Net Income | ¥26,487M | ¥23,008M | ¥23,220M | ¥25,309M |
| EPS | ¥404.95 | ¥348.66 | ¥356.87 | ¥399.67 |
| Operating Margin | 6.30% | 4.64% | 4.27% | 4.96% |
| Balance Sheet | ||||
| Total Assets | ¥726,959M | ¥782,640M | ¥870,205M | ¥920,143M |
| Total Equity | ¥387,768M | ¥417,992M | ¥454,110M | ¥471,934M |
| Total Liabilities | ¥339,191M | ¥364,648M | ¥416,095M | ¥448,209M |
| Cash | ¥41,735M | ¥41,774M | ¥43,969M | ¥45,639M |
| Interest-bearing Debt | ¥132,829M | ¥175,943M | ¥195,095M | ¥223,058M |
| Equity Ratio | 53.34% | 53.41% | 52.18% | 51.29% |
| D/E Ratio | 0.34 | 0.42 | 0.43 | 0.47 |
| Cash Flow | ||||
| Operating CF | ¥34,106M | ¥28,710M | ¥61,911M | ¥41,252M |
| Investing CF | -¥39,595M | -¥41,970M | -¥58,771M | -¥55,038M |
| Financing CF | -¥1,105M | ¥12,352M | -¥1,519M | ¥14,453M |
| Free CF | -¥5,824M | -¥13,281M | -¥3,355M | -¥14,729M |
| Efficiency | ||||
| ROE | 6.83% | 5.50% | 5.11% | 5.36% |
| ROA | 3.64% | 2.94% | 2.67% | 2.75% |
Latest IR Information
-
Kaneka: Q1 Fiscal 2027 Financial Summary
Announces the Q1 results for the fiscal year ending March 2027. Highlights include year-over-year comparisons for net sales, operating income, ordinary income, and net income attributable to owners of the parent. The document includes a breakdown of net sales by...
Read more -
FY2027 Q1 Earnings Presentation
Revenue was 223.0 billion yen, up 12.3% year over year, with operating income of 14.9 billion yen, up 83.1% YoY. Segments Materials/SU Quality of Life, Health Care, and Nutrition performed well. Going forward, growth strategies for each segment are expected...
Read more -
Notice on the Status of Share Buyback
From July 1, 2026 to July 31, 2026, ordinary shares were repurchased. Number of shares acquired: 102,600 shares, total acquisition value: 58,227万3千円. Upper limit: 1,400,000 shares, share buyback period: 2026/5/15–2027/3/24. Cumulative through July 31: 189,300 shares, total value 10億63百万円.
Read more -
Notice regarding the status of share buyback
During the period, ordinary shares were acquired. Number of shares acquired: 53,800; total acquisition cost: ¥304,354,700; method: market purchase. As of the board meeting held on May 14, 2026, the maximum cap is 1,400,000 shares or ¥70 billion, with cumulative...
Read more -
【Kaneka】Status Update on Share Buyback|May 2026
Kaneka purchased 32,900 shares of treasury stock from May 15 to May 31, 2026, totaling 176,448,500 yen. The company plans to continue the buyback.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥5,292
Rating Score: 2.67 (Based on 6 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, as well as engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers. The company was incorporated in 1949 and is headquartered in Tokyo, Japan.